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Four A6-TCR/Peptide/HLA-A2 Structures
that Generate Very Different T Cell Signals
Are Nearly Identical
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The molecular mechanism for how TCR binding to
different APL generates different responses is unclear.
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from a number of laboratories suggest that the half-life³Structural Biology Section
National Institute of Allergy of a TCR/peptide/MHC complex correlates with the type
of signal generated: the longest half-lives generate ago-and Infectious Diseases
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MHC ligand has shown how very different TCR se-
quences can recognize the same antigen, using slightly
different diagonal binding modes, and both produce fullSummary
T cell activation (Ding et al., 1998).
The A6 TCR studied here was expressed by a cytolyticThe interactions of three singly substituted peptide
CD81 T cell clone derived from an HTLV-1-infected pa-variants of the HTLV-1 Tax peptide bound to HLA-A2
tient with the neural degenerative disorder HAM/TSPwith the A6 T cell receptor have been studied using T
(Roman and Osame, 1988; Utz et al., 1996). The TCR iscell assays, kinetic and thermodynamic measurements,
specific for the Tax peptide (LLFGYPVYV) of HTLV-1and X-ray crystallography. The three peptide/MHC li-
presented by HLA-A2. We have assayed a number of Tgands include weak agonists and antagonists with
cell functions of the Tax peptide and many single aminodifferent affinities for TCR. The three-dimensional
acid variants of Tax (Garboczi et al., 1996a; Ding et al.,structures of the three A6-TCR/peptide/HLA-A2 com-
1998; Hausmann et al., 1999).plexes are remarkably similar to each other and to the
Here, we present data for three peptides, P6A, V7R,wild-type agonist complex, with minor adjustments at
and Y8A, which include one weak agonist and two weakthe interface to accommodate the peptide substitu-
antagonists. The weak antagonists inhibit T cell functiontions (P6A, V7R, and Y8A). The lack of correlation be-
when present at 1000-fold molar excess over the Taxtween structural changes and the type of T cell signals
peptide. Despite the different T cell signals that theseinduced provides direct evidence that different signals
APL peptides induce, we could crystallize and determineare not generated by different ligand-induced confor-
the structures of all of them complexed with the A6-mational changes in the abTCR.
TCR and HLA-A2. We compare the structures of these
three complexes with the agonist complex, A6-TCR/
Tax/HLA-A2, whose structure was reported earlier (Gar-Introduction
boczi et al., 1996a). The structures provide a direct visu-
Peptides with single amino acid substitutions (altered alization of cross-reactivity that generates different in-
peptide ligands [APL]) presented by the same MHC mol- tracellular signals. Cross-reactivity is achieved by small
ecule can induce quantitatively and qualitatively differ- structural adjustments: induced fits, where TCR, pep-
ent signals when recognized by the same T cell receptor tide, and MHC residues rearrange to better accommo-
(reviewed in Sloan-Lancaster and Allen, 1996). A strong date the altered peptide. There is, however, no correla-
agonist ligand provided at very low concentrations in- tion between the types of minor structural adjustments
duces T cell cytotoxicity, TCR downregulation, the pro- at the interface and beyond the interface with the type
duction of cytokines, and hyperphosphorylation of the of signal generated inside the cell.
TCR related z chain and the tyrosine kinase ZAP-70.
Weak agonists have the same effects but at 100- to
1000-fold higher ligand concentrations. Some APL are Results and Discussion
antagonists: they inhibit T cell responses by agonists
and are characterized by specific patterns of phosphor- Three Singly Modified Tax Peptides Generate
ylation of ZAP-70 and z chains (Ljunggren et al., 1990; Different T Cell Responses
The capacity of variant Tax peptides V7R, P6A, and
Y8A, which contained single substitutions, to produce‖ To whom correspondence should be addressed (e-mail: dcwadmin@
crystal.harvard.edu). different biological effects upon interaction with the
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Figure 1. T Cell Assays
(A±C) Reactivity of HTLV-1 Tax-specific clone
2G4 to altered Tax peptides. 2G4 was as-
sayed for its capacity to lyse (A) or secrete
IFNg (B) or MIP-1b (C) when presented with
APC pulsed with peptides. Tax, square; V7R,
closed circle; P6A, closed triangle; Y8A, up-
side down closed triangle.
(D) Cell surface TCR downmodulation in-
duced by variant Tax peptides. 2G4 T cells
were exposed to APC pulsed with 1 mM of
the indicated peptides for 5 hr at 378C,
washed, and cell surface TCR was quanti-
tated by flow cytometry. Units are the per-
centage mean fluorescence intensity of TCR
expression relative to T cells cultured with
APCs pulsed with no peptide.
(E) Differential TCR signaling patterns in-
duced by variant Tax peptides. 2G4 T cells
were exposed to APC pulsed with 10 mM of
peptide for 5 min at 378C. Tyrosine phosphor-
ylation of z chains and ZAP-70 was detected
in the ZAP-70 immunoprecipitated complex
(see the Experimental Procedures). Y-axis
values are relative densitometer units for
bands corresponding to p32z, p38z, and
ZAP-70.
(F) P6A and Y8A antagonize secretion of IFNg
induced by Tax. Mitomycin C±treated APC
were pulsed with 1000 nM of peptide for 2 hr
at 378C, washed, and incubated with 2G4
cells for 1 hr at 378C. Tax peptide was then
added at a final concentration of 1 nM and
incubated for 48 hr. Supernatants were as-
sayed for IFNg. Quantitative differences were
analyzed by the Student's t test.
(G) Summary of (A) to (F).
A6-TCR-bearing T cell clone 2G4 was assessed by cyto- induce an antagonist response (Sloan-Lancaster and
Allen, 1996), clone 2G4 was exposed to APC pulsed withtoxicity, cytokine and chemokine secretion, cell sur-
face TCR downmodulation (Valitutti et al., 1995), and either the P6A and Y8A peptides and a negative control
HLA-A2 epitope influenza M1 58-66 and then incubatedphosphorylation of TCR-associated signaling molecules
(Sloan-Lancaster et al., 1994; Madrenas et al., 1995; with 1 nM of the Tax peptide. The effect of preexposure
to candidate antagonist peptides on subsequent inter-Sloan-Lancaster and Allen, 1996). The variant Tax pep-
tide V7R could induce cytotoxicity (Figure 1A) and IFNg action with the Tax peptide was quantitated by IFNg
secretion. The results (Figure 1F) demonstrate that the(Figure 1B) and MIP-1b (Figure 1C) secretion with ap-
proximately 10- to 100-fold more V7R peptide required P6A and Y8A peptides but not the M1 58-66 peptide
produced a significant reduction in IFNg secretion. Simi-to achieve a comparable level of effector function as
that induced by the Tax peptide. In contrast, Tax pep- lar results were obtained when APCs were prepulsed
with 1 nM Tax and then cultured with 1000 nM P6A ortides P6A and Y8A were unable to induce any detectable
effector functions even at a concentration of 1000 nM Y8A (data not shown). No antagonist effect was seen at
10-fold lower concentration of either P6A or Y8A (data(Figures 1A±1C). These results demonstrate that the V7R
peptide is a weak agonist, whereas the P6A and Y8A not shown). These results indicate that the P6A and Y8A
peptides are very weak antagonists (only effective whenpeptides could be null ligands.
While the Tax peptide induced nearly complete cell sur- at 1000-fold higher concentration than the agonist).
To confirm the classification of V7R as a weak agonistface TCR downmodulation following exposure to peptide-
pulsed antigen-presenting cells (APCs) (Valitutti et al., and P6A and Y8A as antagonist peptides for the A6 TCR,
we examined the z chain and ZAP-70 phosphorylation1995), neither P6A nor Y8A was able to induce any de-
tectable cell surface TCR downmodulation (Figure 1D). patterns induced in 2G4 T cells by these peptides (Sloan-
Lancaster et al., 1994; Madrenas et al., 1995; Sloan-Peptide V7R induced TCR downmodulation but to a some-
what lesser extent than the Tax peptide (Figure 1D). Lancaster and Allen, 1996) (Figure 1E). The Tax peptide
induced the characteristic agonist signaling patternThese results again indicate that the V7R peptide but not
P6A or Y8A is able to functionally engage the A6-TCR. (Sloan-Lancaster et al., 1994; Madrenas et al., 1995;
Sloan-Lancaster and Allen, 1996): phosphorylation ofTo examine whether the P6A and Y8A peptides might
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Figure 2. Biacore Data
(A and B) Kinetic binding experiments for
HLA-A2 with wild-type Tax (A) and Tax-V7R
(B). Solid lines are a fit to a 1:1 binding model.
Concentrations of injected protein are indi-
cated. Residuals are below plots.
(C and D) Equilibrium binding experiments (on
separate surfaces from [A] and [B]) for HLA-
A2 with wild-type Tax (C) and Tax-V7R (D).
Solid lines are a fit to a 1:1 binding model.
(E) Fitted parameters from (A)±(D). Errors in
kinetic terms are standard deviations from
multiple experiments; errors in t1/2 and koff/kon
are propagated from these values. Errors in
KD,eq are standard deviations from the nonlin-
ear fits. No binding was seen for HLA-A2 with
Tax-P6A or Tax-Y8A.
TCR-associated z chain producing more of the hy- of an on-rate of 1 3 105 M21s21 and an off-rate of 0.09
s21, or a half-life of approximately 8 sec. The V7R interac-perphosphorylated p38z than the hypophosphorylated
p32z, and phosphorylation of ZAP-70. The V7R peptide tion is almost an order of magnitude weaker, with a KD
of approximately 8 mM, reflecting an on-rate of 6 3 104induced the weak agonist pattern of TCR signaling
(Sloan-Lancaster et al., 1994; Madrenas et al., 1995; M21s21 and an off-rate of 0.5 s21, or a half-life of 1.5 sec.
For the interaction involving P6A and Y8A, no bindingSloan-Lancaster and Allen, 1996): increased p32z rela-
tive to p38z and almost undetectable levels of ZAP-70 was detectable in either kinetic or equilibrium mode.
However, equilibrium analytical ultracentrifugation stud-phosphorylation. Both P6A and Y8A showed a charac-
teristic antagonist pattern: p32z phosphorylation but al- ies of the P6A indicate an affinity of approximately 100
mM, approximately 100-fold weaker than Tax (B. M. B.most no detectable p38z and no detectable ZAP-70
phosphorylation. and D. C. W., unpublished data).
Altogether, the binding results are consistent with the
T cell assays, with the most potent TCR ligand (HLA-The Three Singly Modified Tax Peptides Have Different
Kinetic and Thermodynamic Effects In Vitro A2/wild-type Tax) having the strongest affinity and the
longest half-life, followed by the weakly activating V7RBiacore has been used extensively to characterize TCR-
MHC interactions, providing interaction affinities and ligand with a weaker affinity and shorter half-life, and,
finally, by the P6A and Y8A ligands, which bind veryoften kinetic rate constants (e.g., Davis et al., 1998).
Representative kinetic and equilibrium data for A6-TCR weakly. These effects are not likely to result from alter-
ations in the affinity of the peptides for the MHC, asbinding to HLA-A2 complexed with wild-type Tax and
Tax-V7R peptides are shown in Figure 2. For the kinetic Val-7 and Tyr-8 make little contact with the MHC in the
free HLA-A2/Tax structure (Madden et al., 1993), andexperiments, the data were fit to a 1:1 binding model
over the entire injection period (Figures 1A and 1B; but Tax-P6A/HLA-A2 is a strong agonist ligand for the TCR
clone B7 (Hausmann et al., 1999).see the Experimental Procedures). Good agreement is
observed between the affinities determined kinetically
(the ratio of koff to kon) and those determined by equilib- Three-Dimensional Structure Determinations
of Three TCR/Tax-APL/MHC Complexesrium measurements (Figures 1C and 1D). Figure 1E sum-
marizes the data. The A6-TCR binds HLA-A2/wild-type TCR/peptide/MHC complexes were produced by ex-
pressing the ectodomain of each subunit, a and b ofTax with a KD of approximately 0.9 mM. This is composed
Immunity
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Figure 3. Comparison of TCR/Tax/HLA-A2
and TCR/Tax-APL/HLA-A2 Complexes with
the a1 and b2 Domains Superimposed
(A) Two different TCRs, A6 (red) and B7 (blue).
An arrow shows the location of the Ca domain
that was missing in the A6-TCR/Tax/HLA-A2
structure. The pronounced difference in the
A6 and B7 TCR complexes, both strong ago-
nists, has been described (Ding et al., 1998).
HLA-A2 (light blue and purple) and the bound
peptide (black and yellow) are shown; the a3
domain and b2M were omitted for clarity.
(B) A6-TCR/P6A/HLA-A2 (green) and A6-
TCR/Tax/HLA-A2 complex (orange). Aster-
isks show the locations of the three loops in
the Cb domain (right) that were disordered in
the A6-TCR/Tax/HLA-A2 structure but visible
in the P6A complex.
(C) A6-TCR/V7R/HLA-A2 (magenta) and A6-
TCR/P6A/HLA-A2 complex (green). Arrow
marks the structural difference in the CDR3
loop of the Vb domain.
(D) A6-TCR/Y8A/HLA-A2 (orange) and A6-
TCR/P6A/HLA-A2 complex (green). Straight
arrow marks the structural difference in the
CDR3 loop of the Vb domain. Curved arrow
indicates the sense of the small (1.8 AÊ ) twist
of the b chain. This figure was generated with
RIBBONS (Carson, 1991).
the A6-TCR and heavy chain and b2m of HLA-A2, sepa- (Figures 3C and 3D, arrows) when compared to either of
the nearly identical Tax or P6A complexes. (The figuresrately in bacteria. Each subunit was purified as inclusion
bodies, and the TCR and MHC/peptide were folded in compare the V7R [Figure 3C, magenta] and Y8A com-
plexes [Figure 3D, orange] to the P6A complex [green],vitro and purified before being combined to form TCR/
peptide/MHC complexes as described previously (Gar- because the P6A complex is a more complete model
than Tax.) In the V7R complex, the six CDR3b residuesboczi et al., 1992, 1996b).
The three crystal structures, P6A, V7R, and Y8A, were Leu-98 to Gly-101, encoded by the D region, and the N
additions Arg-102 and Pro-103, are rearranged to ac-determined by molecular replacement and refined to
2.8 AÊ resolution (see the Experimental Procedures). commodate the large V7R arginine side chain (Figure
3C, arrow). While the Ca position of Leu-98 differs by
only 0.8 AÊ , Gly-100, Gly-101, and Arg-102 at the apexTCR/Tax-APL/MHC Complexes that Signal Differently
of the CDR3b loop differ substantially more; for example,Have Very Similar Structures
Gly-101 has moved outwardly in the interface by 4.4 AÊ . AWhen the HLA-A2 a1a2 domains are superimposed, the
similar structural difference is found in the Y8A complexA6-TCR molecules of all three Tax-APL complexes su-
(Figure 3D, lower arrow), where Leu-98 also differs byperimpose very closely (Figure 3). The similarity in struc-
0.8 AÊ and the glycines at 100 and 101 have moved andture is greatest in the P6A complex where, when the
may be partially disordered judging by the weak electrona1a2 domains are superimposed on the A6/Tax/HLA-
density at their positions. The structural differences inA2 complex (root mean square deviation [rmsd] 5 0.2 AÊ ;
the V7R complex are restricted to the interface betweenfor 180 Ca atoms), the TCRs are positioned almost iden-
the TCR and peptide/MHC, but in the Y8A complex thetically (rmsd 5 0.6 AÊ ; for 320 Ca atoms) (Figure 3B). Yet,
b subunit of the TCR is tilted slightly upward (z1.8 AÊthe Tax peptide causes the TCR to generate a strong
measured at the top of Cb; Figure 3D, upper arrow).agonist signal and the P6A peptide is a weak antagonist.
There is apparently no correlation between the overallBoth the V7R and Y8A complexes, the former a weak
shape of the complex or the rearrangements at the inter-agonist and the latter a weak antagonist, have a similar
structural difference at the CDR3 loop of the Vb domain face and the type of signal generated by the TCR.
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Figure 4. Surface Areas of Peptide Atoms
Buried by the A6-TCR in the TCR/Peptide/
MHC Interface
(A) The structure of the Tax peptide (LLFGYP-
VYV) in the A6-TCR/Tax/HLA-A2 complex.
The radius of the large spherical atoms is
shown proportional to the solvent-accessible
surface of the MHC bound peptide that is
buried by the TCR. Carbons are yellow, oxy-
gens red, and nitrogens blue. Buried solvent-
accessible surface area summary: total, 2073
AÊ 2; MHC 1 peptide, 1031 AÊ 2; TCR, 1042 AÊ 2;
peptide alone, 336 AÊ 2. Areas calculated with
a 1.4 AÊ radius probe using the program AC-
CESS (Scott Presnell, ZymoGenetics). Pep-
tide represents only the peptide surface bur-
ied by the TCR.
(B) The structure of the P6A peptide repre-
sented as in (A). Summary: total, 2046 AÊ 2;
MHC 1 peptide, 1024 AÊ 2; TCR, 1022 AÊ 2; pep-
tide alone, 336 AÊ 2.
(C) The structure of the V7R peptide repre-
sented as in (A). Summary: total, 2085 AÊ 2;
MHC 1 peptide, 1066 AÊ 2; TCR, 1019 AÊ 2; pep-
tide alone, 366 AÊ 2.
(D) The structure of the V8A peptide repre-
sented as in (A). Summary: total, 2012 AÊ 2;
MHC 1 peptide, 1010 AÊ 2; TCR, 1002 AÊ 2; pep-
tide alone, 262 AÊ 2. Figure generated with RIB-
BONS (Carson, 1991).
Interfacial Surface Areas Vary by Only a Few surface area buried by the TCR. This is almost entirely
due to the loss of the contacts with the tyrosine ringPercent in Differently Signaling
TCR/Tax-APL/MHC Complexes and hydroxyl group (compare Figures 4A to 4D).
Changes in the overall solvent-accessible surfaceThe solvent-accessible surface area buried in an inter-
face often gives an indication of the stability of that area buried in an interface have been estimated to con-
tribute about 25 cal M21 per AÊ 2 of ªhydrophobicº freeinterface (e.g., Janin and Chothia, 1990). The difference
in the solvent-accessible surface area buried in the for- energy (Janin and Chothia, 1990). The largest change
observed in the Tax-APL complexes (a total of 60 AÊ 2 ofmation of the TCR to peptide/MHC interface relative to
the Tax interface is a decrease of 1% (226 AÊ 2) and 3% hydrophobic surface area for the Tax-Y8A structure)
would only account for about 1.5 Kcal M21 of the ob-(-60 AÊ 2) for the two weak antagonists, P6A and Y8A, and
a slight increase of ,1% (112 AÊ 2) for the weak agonist, served free energy differences of at least 2.7 Kcal M21
(assuming a conservative estimate of 100 mM for the A6-V7R (Figure 4A, caption). These differences are all less
than the differences observed between the two agonist TCR-HLA-A2/Tax-Y8A dissociation constant), implying
that other effects discussed below are also important.TCR complexes with the A6- and B7-TCRs (78 AÊ 2) (Fig-
ure 4A).
The solvent-accessible surface areas of the peptides Detailed Structural Accommodations to the Peptide
Substitutions in the TCR/MHC InterfacesTax and P6A buried by the A6 TCR are identical (336 AÊ 2)
(Figure 4A, caption) and are distributed over the peptide Antagonist Peptide P6A Shows No Structural Changes
Relative to the Tax Peptideatoms identically. This implies that the two peptides are
contacted essentially identically by the TCR (compare The substitution of alanine for proline at position 6 of
the peptide removes two methylene groups from theFigures 4A and 4B), but the result is a different signal,
a strong agonist versus a weak antagonist. TCR to MHC/peptide interface and results in a free am-
ide group in place of the amino group of the proline.The weak agonist peptide, V7R, has a 10% larger
surface area buried by TCR than the strong agonist, Tax No substantial structural alterations result in the TCR/
peptide/MHC complex from this substitution (Figure 5A).(Figure 4C, caption). This is due to the increased surface
area of the arginine side chain that is buried in V7R The amide group of Ala-6 of the peptide is within hydro-
gen bonding distance of an ordered water molecule thatrelative to the valine in Tax (compare Figures 4A and 4C).
This energetically favorable increase in buried surface is found in the cavity created by the removal of the
proline methylene groups (Figure 5A, black sphere). Themust be balanced by the unfavorable burial of the posi-
tive charge of the guanidinium group and possibly by hydroxyl group of Ser-100 of CDR3a and an imidazole
nitrogen from His-70 of HLA-A2 are also in the vicinity ofdistortions to the TCR, to result in an almost 10-fold
increase in the dissociation constant (Figure 2). the water and may form hydrogen bonds. The imidazole
reorients by about 408, possibly to optimize contact withThe substitution of the small alanine side chain for
the large tyrosine side chain at peptide position 8 (Y8A) the water. Leu-98 of CDR3b moves about 0.7 AÊ into the
cavity making contact with Trp-101 of CDR3a.results in a decrease of 22% (-75 AÊ 2) in the peptide
Immunity
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Figure 5. Structural Changes in the TCR to Tax-APL/MHC Interfaces
(A) The P6A complex (colored) superimposed on the Tax complex (gray). Potential hydrogen bonds are dashed red lines. Labels for peptide
residues are underlined.
(B) The V7R complex (colored) superimposed on the Tax complex (gray).
(C) The Y8A complex (colored) superimposed on the Tax complex (gray). This figure was generated with RIBBONS (Carson, 1991).
With so little structural difference, it is difficult to ratio- results in a displacement of the CDR3b loop in the A6-
TCR in order to accommodate the bulky side chain innalize the difference in half-lives between the Tax and
P6A complexes, which is probably at least two orders the TCR/MHC interface (Figure 5B). The guanidinium
group of the arginine is surrounded by the Ser-100 hy-of magnitude. The introduction of a larger cavity in the
interface and the reduction in the complementarity be- droxyl group of CDR1a and the carbonyl oxygens of
three CDR3b residues, Gly-97, Ala-99, and Gly-101, alltween the TCR and MHC/peptide are probably contrib-
uting factors (see below). The observation that these within hydrogen-bonding distance. The three carbonyl
groups apparently stabilize the buried charge of thecomplexes have such similar structures, while one is a
strong activator and the other is not, is evidence that guanidinium group by delocalizing the electrostatic
charge through their solvent-accessible peptide amideAPL do not produce different signals as the result of
changing the conformation of the abTCR or the relative groups, as previously observed for other buried charges
(Quiocho et al., 1987). Gly-101 is displaced outward byarrangement of the TCR and MHC molecule.
Peptide V7R Induces a Large Change in the TCR Loops 4.4 AÊ (Figure 5B), which allows the whole arginine side
chain to be accommodated within the TCR interface.but Is a Weak Agonist
The substitution of a large, positively charged arginine The repositioned CDR3b loop results in the loss of
two potential hydrogen bonds from Gly-101 to MHCside chain for a valine at position 7 of the Tax peptide
Four A6-TCR/Peptide/HLA-A2 Structures
51
Figure 6. Cavities in the A6-TCR to Peptide/
HLA-A2 Interface
(A) A cavity adjacent to peptide residue 6 is
larger in the P6A complex (red mesh) than in
the Tax complex (blue mesh). A bound water
molecule (green) is positioned to hydrogen
bond to the amide group of peptide alanine
P6. The view is through the TCR onto the
peptide/MHC interface. Position 1 of the Tax
peptide is to the left.
(B) A cavity adjacent to peptide residue 7 is
larger in the V7R complex (red mesh) than in
the Tax complex (blue mesh).
(C) A cavity adjacent to peptide residue 8 is
found in the Y8A complex (red mesh) but not
in the Tax complex. Figure generated using
the program Quanta (MSI). Gaps calculated
using the program SURFNET (Laskowski,
1995).
residues 150 and 155 found in the Tax complex (Gar- tyrosine ring made van der Waals contacts with CDR3b
residue Leu-98 and MHC Val-76 (Figure 5C, gray). Re-boczi et al., 1996a) and in rearrangements in the TCR
pocket that binds to Tyr-5 of Tax. The movement of moval of the tyrosine ring and replacement by an ala-
nine side chain removes these two interactions. As athe loop includes a displacement of Pro-103 by 2.3 AÊ
(measured at Cb), which apparently causes a displace- result, Glu-30 moves away from the peptide by about
0.7 AÊ , and Leu-98 moves 0.9 AÊ toward Trp-101 ofment of Tyr-5 of the peptide. Two potential hydrogen
bonds from Arg-95 are lost, one to the Tyr-5 hydroxyl CDR3a. The CDR3b loop rearrangement is similar to
that in the V7R complex except the loop is displacedgroup and one to the carbonyl oxygen of Pro-103. Arg-
95 rearranges to form a potential hydrogen bond with the slightly less; for example, Gly-101 is displaced only
3.5 AÊ rather than 4.4 AÊ . The loop displacement breaksCDR3a carbonyl oxygen of G-102 (Figure 5B). Electron
density corresponding to a potential water molecule is a hydrogen bond between the carbonyl oxygen of Leu-
98 and the amide group of Tyr-8 of the peptide and twoobserved in a cavity introduced adjacent to Arg-95 that
may make a hydrogen bond with the Ne atom. hydrogen bonds from the carbonyl and amide groups
of Gly-101 to MHC residues 150 and 155. (The alterationThe energetic costs of these large local rearrange-
ments are difficult to assess, but the presence of flexible of TCR to MHC contacts by single substitutions in pep-
tide residues has been inferred earlier from T cell activa-glycines at three positions, 97, 100, and 101, in the
CDR3b loop would be expected to facilitate such an tion studies with murine H-2Kb/VSV-peptide ligands
[Ono et al., 1998].) Arginine-95 of CDR3b is displaced,accommodation to a large peptide substitution. It is
interesting to see how the burial of such a large and breaking hydrogen bonds to the carbonyl oxygen of
residue Pro-103 across the loop and to the hydroxylelectrostatically charged residue was accommodated
in the TCR interface with a change in dissociation con- group of Tyr-5 of the peptide. The displaced Arg-95 is
within hydrogen bonding distance of the CDR3a car-stant of only 10-fold, resulting in sufficient cross-reactiv-
ity to be a weak agonist. bonyl groups of Asp-99 and Gly-102 (not shown on Fig-
ure 5C).Peptide Y8A Induces TCR Changes Similar to V7R,
the Weak Agonist, but Is Itself a Weak Antagonist Although the CDR3b loop is displaced similarly in the
Y8A complex as in the V7R complex, the former is anIn the Tax complex, the peptide Y8 hydroxyl group was
hydrogen bonded to CDR2b residue Glu-30, and the antagonist and the latter a weak agonist.
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Increases in the Size of Cavities in the TCR/Peptide/ recognizing the tyrosine-5 peptide side chain. This might
be expected for a molecular interaction where the inter-MHC Interface May Account for Some
face can adapt to achieve its best fit by small atomicof the TCR Affinity Differences
displacements and has been suggested by TCR speci-Each of the Tax-APL complexes has a new or enlarged
ficity studies (Ausubel et al., 1996).cavity in the TCR to peptide/MHC interface as the result
of a less perfect fit of the TCR to the peptide/MHC
Implications for TCR Signalingcomplex (Figure 6). In the Tax complex, there are two
The three structures of A6-TCR/HLA-A2 complexes con-such internal cavities, one between the side chain of
taining singly substituted variants of the Tax peptidepeptide Pro-6 and the a1-domain a helix of the MHC
studied here provide direct evidence that TCR/MHCmolecule and the other above peptide position 6 (Fig-
complexes that generate different signals in T cells doures 6A and 6B, blue). In the P6A complex, the first
not have different conformations. P6A, an antagonist,cavity is increased in volume by 18 AÊ 3 (Figure 6A, red),
is almost identical to Tax, a strong agonist. Small andand in V7R the second cavity is increased in volume by
similar alterations are seen in CDR3b of V7R, a weak40 AÊ 3 (Figure 6B, red). In the Y8A complex, a new cavity
agonist, and Y8A, an antagonist. P6A and Y8A, whichadjacent to the substituted residue is found with a vol-
differ in the overall rearrangement of the TCR domains,ume of 55 AÊ 3 (Figure 6C, red). Enlarged and novel cavities
are both weak antagonists. Most of the structural differ-in this interface would be expected to decrease the
ences are confined to TCR loops in the TCR to peptide/binding affinity of the TCR. The magnitude of that
MHC interface where they appear to be accommodatingchange is difficult to estimate, but studies of the stability
for the changes in ligand composition (Figure 5). Theof the native conformation of folded proteins suggest
differences between two different TCR, A6 and B7,that the free energy increases by about 24 to 33 cal
bound to Tax/HLA-A2, both of which generate strongM21 per AÊ 3 of cavity volume (Eriksson et al., 1992).
agonist signals, is much greater, both in the interfaceThese cavities might then be expected to reduce the
and in the overall tilt of TCR domains than that describedstability by about 0.5 to 1.5 Kcal M21, which is at
here for the Tax-APL complexes that generate differentmost a 10-fold effect on the equilibrium constant. (For
signals.discussion of other complicating factors, see Eriksson
These observations provide direct structural evidenceet al., 1992; Guo et al., 1993.) Large cavities have also
that no particular structural arrangement of the abTCRbeen found in the structure of a weak affinity 2C-TCR/
chains relative to the MHC molecule encodes the differ-dEV8H/2Kb murine complex formed in vitro (Garcia et
ent signaling possibilities. This conclusion is subject toal., 1998).
the caveat that because the crystal structures containAn ordered water molecule is found in the enlarged
only the a and b ectodomains of the TCR, the contribu-cavity in the P6A complex within hydrogen bonding dis-
tions, if any, of the d, e, g, and z subunits and the trans-tance of the peptide amide group created by the substi-
membrane segments of all of the subunits are unknowntution of alanine for proline at position 6 (Figure 6A,
at this time. What the current observations indicate aregreen sphere). The entropic cost of ordering bound wa-
that no consistent structural difference is seen propa-ter molecules is estimated to be from 0 to 2 Kcal M21,
gated from the peptide binding site that could carrywith the higher value applying only to very firmly bound
the different messages to these other subunits that arewaters (Dunitz, 1994). The high temperature factor of
expected to be at the base of the abTCR, surroundingthe water observed here (B 5 50 AÊ 2) suggests that the
the ab constant domains (Ding et al., 1998; reviewed inentropic cost would be at the low end of this range.
Garcia et al., 1999).Thus, the observed changes in cavity volume and bound
How does the inside of a T cell know when a TCR hassolvent probably account for only a fraction of the desta-
engaged a peptide/MHC ligand and how does it knowbilization of the TCR dissociation constant in the differ-
which signal(s) to initiate? It is clear that one peptide/
ent Tax-APL complexes.
MHC ligand does not physically cross-link two abTCR
complexes into a 1:2 complex, analogous to the model
Differences in the Complementarity of Fit between for human growth hormone where transmission of the
TCR and Tax-APL/MHC Complexes signal into the cell is by alteration in the relative positions
Lawrence and Colman (1993) have described a shape of the cytoplasmic domains of the receptor molecules.
complementarity function (SC) that estimates from the Also, structural data on human and murine TCR/peptide/
atomic coordinates in an interface the complementarity MHC complexes provide no evidence for conformational
in curvature between two interacting protein surfaces. changes induced in TCR by binding ligand that are con-
(The overall shape complementarity of the A6/Tax/HLA- sistent with sending the signal that ligand engagement
A2 and 2C/dEV8/H-2Kb TCR/MHC complexes was re- has occurred into the cell (Garboczi et al., 1996a; Garcia
ported earlier (Garcia et al., 1998; Ysern et al., 1998; but et al., 1996; Ding et al., 1998; reviewed in Garcia et al.,
see also Garcia et al., 1999). Plots of SC on the interfaces 1999). This lack of evidence for a conformational change
studied here show holes in the interface in the P6A, V7R, also argues against models where the TCR to ligand
and Y8A complexes, as well as decreases in comple- interaction triggers a conformational change that subse-
mentarity around the peptide substitutions (B. M. B. et quently favors oligomerization or aggregation (reviewed
al., 1999, Cold Spring Harbor Symposium of Quantitative in Sloan-Lancaster and Allen, 1996) and does not favor
Biology, in press). In each Tax-APL complex, the re- models where signaling differences may result from
arrangements in the TCR loops resulting from the pep- twists in TCR/MHC interface affecting coreceptor CD8
tide substitutions at positions 6, 7, and 8 also affect binding (Luescher et al., 1995a, 1995b; note, however,
Alam et al., 1999).the complementarity of binding at the central pocket
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(kindly supplied by Dr. Larry Samelson, NIH) and immunoblottingThe possibility that oligomerization or aggregation of
with the anti-phosphotyrosine antibody 4G10 (Upstate Biotechnol-TCR/MHC pairs occurs simply because TCR interaction
ogy) and horseradish peroxidase-coupled goat anti-mouse IgG (Bio-with ligand could create a larger oligomerization surface
Rad) as previously described (Hemmer et al., 1998). Immunoblots
(Brown et al., 1993) remains possible. Data indicating a were developed with SuperSignal enhanced chemiluminescence
correlation between the half-life of TCR/MHC com- (Pierce Chemical). Quantitation of the phosphotyrosine signal in
bands corresponding to the ZAP-70, p32z, and p38z was performedplexes and the type of signal generated suggests that
by laser densitometry (Molecular Dynamics).the persistence of the liganded state may allow assem-
bly with coreceptors and other TCR/MHC complexes
Biacore Measurements(reviewed in Davis et al., 1998). The finding that all TCR/
Sequences encoding a heterodimeric coiled coil (O'Shea et al., 1993)MHC complexes crystallized to date have a similar diag-
were added to the C termini of the TCR a and b ectodomains. Theonal mode of TCR interaction is consistent with a con-
cysteines encoding the interchain disulfide bond were also reintro-
served assembly mechanism (Garboczi et al., 1996a; duced, allowing formation of the interchain disulfide bond. The free
Garcia et al., 1996, 1998; Ding et al., 1998; Wang et al., cysteine at position b192 was replaced with alanine, and a free
cysteine was added to the C terminus of the extended b chain for1998). Models where persistently liganded TCR com-
coupling the TCR to a CM5 sensor chip by thiol exchange. Measure-plexes segregate on the membrane, without explicit
ments were performed on a Biacore 1000. All experiments wereoligomeric contacts (Janeway et al., 1989), for example
performed on at least two surfaces of different receptor densitiesbecause their mobility has been altered, are not ruled
in 10 mM HEPES, 150 mM NaCl, 3 mM EDTA, and .0005% surfactant
out. P-20 (pH 7.4), at 258C. For kinetic experiments, data were collected
The possibility that abTCR exist on membranes as at 10 hz and the flow rate was 100 mL/min. For equilibrium experi-
two ab molecules connected by CD3 and z chains (Fer- ments, the flow rate was 10 mL/min. For kinetic data analysis, identi-
cal injections over a mock cysteine surface were subtracted fromnaÂ ndez-Miguel et al., 1999) would permit an allosteric
the data, and the entire association and dissociation phases weremodel of signal transmission consistent with the struc-
included in the fit (excluding approximately 2 sec at the start oftural data whereby the two TCR/MHC units could
each phase). Mass transport effects were not present under any
change position with respect to each other without conditions studied. For equilibrium data analysis, equilibrium values
changing their internal conformation (e.g., to allow two were determined by averaging the response over the final 15 sec
MHC molecules to engage simultaneously the two ab of the injection and then subtracting averaged response values from
identical injections over a mock cysteine surface. Data fitting wasTCRs in one dimeric, (abTCR)2 ). When two long-lived
performed using Biaevaluation 3.0 (Biacore). Extinction coefficientsMHC/peptide ligands were engaged to the same diva-
were determined using the Edelhoch method (Pace et al., 1995):lent TCR complex, the new allosteric state induced
95839 M21 cm21 for HLA-A2/Tax and 84503 M21 cm21 for the A6-could persist long enough for further assembly to occur
TCR construct with the coiled coil.
or for recognition of this structural transition from inside The residuals for the fits to the kinetic data displayed some sys-
the cell. This model is analogous to models of cytokine tematic asymmetry. For the V7R interaction, much of this can be
attributed to the difficulties of examining low-affinity interactions.receptor signaling involving allosteric changes in pre-
However, this should be less of a problem for the wild-type interac-formed divalent (dimeric) receptors (Gadella and Jovin,
tion, yet similar asymmetry was observed. Fits to more complicated1995; Naismith et al., 1995; Damjanovich et al., 1997;
models did improve the residuals, but these models could be ex-Livnah et al., 1999; Remy et al., 1999).
cluded due to experimental design or unrealistic parameters. We
chose to include a term for linear drift in the 1:1 binding model,
Experimental Procedures which resulted in improvement. However, we cannot rule out a more
complicated binding scheme. We note that similar deviations from
Cytotoxicity, IFNg, and MIP-1b Assays a simple 1:1 model have been observed by others examining TCR-
T cell assays were performed as described previously (Ding et al., MHC/peptide interactions by Biacore.
1998).
Crystallization, Data Collection, and Structure DeterminationTCR Downmodulation
Crystals of the P6A, V7R, and Y8A complexes were made by mixingAntigen-presenting cells (APC) were HLA-A2 transfected Hmy2.C1R
A6-TCR (12 mg/ml) with HLA-A2/peptide complexes, both in 10 mMcells pulsed with 1000 nM peptides for 1 hr at 378C. APCs (1 3 105)
MES [pH 6.5], 50 mM NaCl, and 0.5 mM EDTA, and seeding (Garbocziwere incubated with 1 3 105 2G4 T cells for 5 hr at 378C. Cells
et al., 1996a). Seeds were made by dilution (50 mM MOPS (pH 7.0),were washed and stained with PE-conjugated anti-CD8 and FITC-
75 mM MgSO4, and 13% PEG 8000) of crushed A6-TCR/Tax/HLA-A2conjugated anti-TCR (Becton-Dickinson). TCR surface expression
crystals. Crystals were harvested by flash cooling in liquid nitrogenwas quantitated by the mean fluorescence intensity (MFI) of the
(Garboczi et al., 1996a).FITC signal. Relative units were calculated as the percentage MFI
Diffraction data for the P6A and V7R complexes were recordedrelative to T cells cultured with APCs pulsed with no peptide (identi-
on a Mar345 detector (Mar Research) (P6A: d 5 240 mm, 18 oscilla-fied as 100).
tion; V7R: d 5 274 mm, 18 oscillation) with an Elliot GX-13 rotating
anode source collimated by double mirrors (l 5 1.54 AÊ ). Data forAntagonism Assay
Y8A crystals were collected on an ADSC 2K CCD detector (0.58Mitomycin C±treated HLA-A2 transfected Hmy2.C1R cells (Ding et
oscillations, d 5 125.9 mm, l 5 0.908 AÊ ; CHESS A1 beamline). Y8Aal., 1998) were pulsed with 1000 nM of candidate antagonist pep-
diffraction was anisotrophic, and data are incomplete near the btides for 2 hr at 378C, washed, and 1 3 105 cells were incubated
axis. Data were integrated and scaled with DENZO and SCALEPACKwith 1 3 105 2G4 T cells for 1 hr at 378C. Tax peptide was added at
(Otwinowski and Minor, 1997) (Table 1).concentrations of 0.1 to 10 nM and incubated for 48 hr. Supernatants
The initial model included the heavy chain and b2m of HLA-A2were assayed for IFNg content as previously described (Ding et al.,
and the Va, Vb, and Cb domains of the A6-TCR with the peptide1998).
and CDR loops (z60 residues) omitted. For the P6A complex, after
rigid-body refinement, the Rfree was .393 (Rcrys 5 .359) with data fromPhosphorylation of TCR-Associated Signaling Components
15±3.2 AÊ . The reflections used to calculate Rfree were the same set2G4 T cells (1 3 105) were incubated for 5 min with 2 3 105 HLA-
used in the refinement of the A6-TCR/Tax/HLA-A2 complex (Gar-A2-Hmy2.C1R cells pulsed with 10 mM peptides. Tyrosine phosphor-
boczi et al., 1996a). Electron density calculated from the rigid-bodyylation of TCR-associated chains and ZAP-70 was detected by im-
munoprecipitation with a polyclonal rabbit anti-ZAP-70 antisera refined model showed the missing Ca domain. The Ca domain from
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Table 1. Crystallographic Data
P6A V7R Y8A
A. Cell Parameters (space group C2)
a (AÊ ) 226.95 224.86 224.67
b (AÊ ) 48.76 48.89 48.46
c (AÊ ) 94.55 94.46 93.74
b (deg.) 90.79 90.49 90.46
B. Data Collection
Resolution (AÊ ) 25.0±2.8 25.0±2.8 25.0±2.8
Mosaicity (deg.) 0.95 0.74 1.1
No. unique reflections 25752 23577 21020
Average redundancya 3.1 (2.5) 2.1 (1.3) 2.2 (1.8)
Completeness (%) 98.2 (83.2) 91.6 (60.8) 87.9 (87.9)
Average I/s 15.1 (3.7) 12.2 (1.4) 13.5 (2.3)
Rmergeb 0.076 (0.26) 0.071 (0.53) 0.063 (0.215)
C. Refinement (25.0±2.8 AÊ all data with F . 0.0)
No. reflections (free)c 23047 (2705) 21094 (2481) 18831 (2189)
Rcrystd, (Rfree) 0.216 (0.273) 0.243 (0.290) 0.247 (0.287)
Rmsd bondse (AÊ ) 0.007 0.008 0.01
Rmsd anglesf (deg.) 1.27 1.5 1.7
Ramachandran Plotg
Favored (%) 83.2 79.3 79.3
Allowed (%) 16.0 18.9 19.3
Generous (%) 0.8 1.8 1.4
a Numbers in parentheses are for final shell 2.9±2.8 AÊ .
b Rmerge 5 ShSi|Ii(h) 2 ,I(h.)|/ShSiIi(h), where Ii(h) is the ith measurement and ,I(h). is the weighted mean of all measurements of I(h).
c (free) are number of reflections in free set.
d Rcryst and Rfree 5 Sh||F(h)obs|2|F(h)calc||/Sh|F(h)obs| for reflections in the working and test sets, respectively.
e Bond length rmsd from ideal.
f Bond angles rmsd from ideal.
g As defined in PROCHECK (Laskowski et al., 1993).
the B7-TCR/Tax/HLA-A2 structure (Ding et al., 1998) was placed V7R complexes were not refined with torsion-angle dynamics simu-
lated annealing. For the Y8A complex, 21 water molecules wereinto this electron density and refined as a rigid-body to an Rfree 5
.379 (Rcryst 5 .349). 3Fo-2Fc and Fo-Fc electron density maps calcu- found at the same locations as in the Tax complex. Because of the
quality of the data at high resolution (Table 1), no solvent was in-lated from the new model were used for rebuilding. Omit maps
were calculated by CNS torsion-angle dynamics refinement omitting cluded in the V7R complex model.
20±30 residues at a time (BruÈ nger, 1992; Pannu and Read, 1996;
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